Live Breaking News & Updates on Discussion Session Date

Stay updated with breaking news from Discussion session date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Triumvira Immunologics Highlights Positive Phase 1 Clinical Data on TAC01-HER2 in Solid Tumors at ASCO 2023 Annual Meeting

/PRNewswire/ Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the. ....

United States , South San Francisco , Deyaa Adib , Prnewswire Triumvira Immunologics , David Schull , Benjaminl Schlechter , Benjamin Schlechter , Ignacio Guerrero Ros , Triumvira Immunologics , Dana Farber Cancer Institute , Harvard Medical School , American Society , Triumvira Immunologics Inc , Society Of Clinical Oncology , Annual Meeting , Senior Physician , Gastrointestinal Oncology , Chief Medical Officer , Principal Investigator , Investigating Safety , Refractory Solid Tumors , Attending Physician , Medical Oncology , Dana Farber Cancer , Developmental Therapeutics , Session Display Date ,

Antengene To Present Latest Results from TORCH-2 Study of ATG-008 in Advanced Solid Tumors in Poster Discussion at ASCO 2023

/PRNewswire/ Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to. ....

South Korea , United States , Mccormick Place , Hong Kong , Peter Qian , Asia Pacific , Hong Kong Stock Exchange , Prnewswire Antengene Corporation Limited , Company Annual , Eastern Cooperative Oncology Group , Antengene Corporation Limited , American Society For Clinical Oncology Annual Meeting , Antengene Corporation , Mccormick Place Convention Center , Corporation Limited , Clinical Oncology Annual Meeting , Poster Discussions , Poster Discussion , Family Zhang , Chief Medical , Developmental Therapeutics , Discussion Session Date , Central Time , Beijing Time , Cervical Cancer Cohort , Nasopharyngeal Carcinoma ,

Tvardi Therapeutics Announces Presentation of Data from the Phase 1 Trial of TTI-101, a STAT3 inhibitor, in Advanced Solid Tumors at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

HOUSTON (BUSINESS WIRE) May 25, 2023 ....

United States , Imran Alibhai , Sara Manning , Apostoliam Tsimberidou , American Society Of Clinical Oncology , Tvardi Therapeutics Inc , American Society , Clinical Oncology , Poster Discussion Session , Targeted Agents , Session Display Date , Board Number , Discussion Session Date , Tvardi Investor , Business Wire ,

Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision. ....

United States , Lee Cranmer , Gopa Iyer , Clinical Research Excluding Trials , Memorial Sloan Kettering Cancer Center , Fred Hutch Cancer Center , Aadi Bioscience Inc , Prnewswire Aadi Bioscience Inc , Poster Session , Molecularly Targeted Agents , Memorial Sloan Kettering Cancer , Session Display Date , Board Number , Discussion Session Date , Clinical Research Excluding , Poster Discussion Session , Fred Hutch Cancer , Aadi Bioscience , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Trade Show News , Clinical Trials Amp Medical Discoveries ,

Zentalis Announces Presentation of Positive Phase 1b Data

Strong anti-tumor activity shown in a platinum-resistant ovarian cancer population, with a confirmed ORR of 50.0% and mPFS of 7.4 months in combination. ....

San Diego , United States , New York , Kimberly Blackwell , Premalh Thaker , Joyce Liu , Emily White , Danielle Cantey , Division Of Gynecologic Oncology , Zentalis Pharmaceuticals , Gynecological Oncology Clinical Research , Dana Farber Cancer Institute , Washington University School Of Medicine , Solebury Strategic Communications , Exchange Commission , Pharmaceuticals Inc , Chief Executive Officer , Safety Results , Frequent Grade , Associate Chief , Clinical Research , Gynecologic Oncology , Dana Farber Cancer , Washington University School , Board Number , Discussion Session Date ,